Role of NF-Kappa B Signaling in X-Box Binding Protein 1 (XBP1)-Mediated Antiestrogen Resistance in Breast Cancer
Abstract
Breast cancer is the most common cancer type among women, with 70% of the patients is estrogen receptor positive (ER+) and receives endocrine therapy (1). However, most patients develop antiestrogen resistance after long-term exposure. Overcome antiestrogen resistance will significantly improve the long-term treatment outcome of ER+ breast cancer patients. XBP1 is a known factor that promotes antiestrogen resistance in breast cancer (2-3). The overall hypothesis of this grant is that NFkB signaling is downstream of XBP1 pathway and is essential for XBP1 mediated antiestrogen resistance in breast cancer.
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 01, 2013
- Accession Number
- ADA594159
Entities
People
- Rong Hu
Organizations
- Georgetown University